Despite the tremendous success of targeted and conventional therapies for lung cancer, therapeutic resistance is a common and major clinical challenge. RNF8 is a ubiquitin E3 ligase that plays essential roles in the DNA damage response; however, its role in the pathogenesis of lung cancer is unclear. Here, we report that RNF8 is overexpressed in lung cancer and positively correlates with the expression of p-Akt and poor survival of patients with non-small-cell lung cancer. In addition, we identify RNF8 as the E3 ligase for regulating the activation of Akt by K63-linked ubiquitination under physiological and genotoxic conditions, which leads to lung cancer cell proliferation and resistance to chemotherapy. Together, our study suggests that RNF8 could be a very promising target in precision medicine for lung cancer.
RNF8-mediated regulation of Akt promotes lung cancer cell survival and resistance to DNA damage.
Yongjie Xu,Yumeng Hu,Tao Xu,K. Yan,Ting Zhang,Qin Li,Fen-Lei F Chang,Xueyuan Guo,Jingyu Peng,Mo Li,Min Zhao,Hongying Zhen,Luzheng Xu,Duo Zheng,Li Li,G. Shao
Published 2021 in Cell Reports
ABSTRACT
PUBLICATION RECORD
- Publication year
2021
- Venue
Cell Reports
- Publication date
2021-10-01
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-51 of 51 references · Page 1 of 1
CITED BY
Showing 1-39 of 39 citing papers · Page 1 of 1